Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Shares Issued (2016 - 2025)

Historic Shares Issued for Harvard Bioscience (HBIO) over the last 17 years, with Q2 2025 value amounting to $46000.0.

  • Harvard Bioscience's Shares Issued fell 7566.14% to $46000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $207000.0, marking a year-over-year decrease of 5129.41%. This contributed to the annual value of $380000.0 for FY2024, which is 5913.98% down from last year.
  • Harvard Bioscience's Shares Issued amounted to $46000.0 in Q2 2025, which was down 7566.14% from $161000.0 recorded in Q4 2024.
  • Harvard Bioscience's Shares Issued's 5-year high stood at $1.9 million during Q1 2021, with a 5-year trough of $15000.0 in Q1 2024.
  • Moreover, its 5-year median value for Shares Issued was $175000.0 (2024), whereas its average is $327937.5.
  • As far as peak fluctuations go, Harvard Bioscience's Shares Issued soared by 204285.71% in 2021, and later crashed by 9838.88% in 2022.
  • Quarter analysis of 5 years shows Harvard Bioscience's Shares Issued stood at $405000.0 in 2021, then tumbled by 42.96% to $231000.0 in 2022, then dropped by 10.82% to $206000.0 in 2023, then fell by 21.84% to $161000.0 in 2024, then plummeted by 71.43% to $46000.0 in 2025.
  • Its Shares Issued stands at $46000.0 for Q2 2025, versus $161000.0 for Q4 2024 and $15000.0 for Q3 2024.